Ascendis Pharma AS (ASND)
138.79
-0.91
(-0.65%)
USD |
NASDAQ |
Dec 24, 16:00
Ascendis Pharma Profit Margin (Quarterly): -171.5% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Novo Nordisk AS | 38.28% |
| Evaxion Biotech AS | -64.14% |
| Trinity Biotech PLC | -31.41% |
| Akari Therapeutics PLC | -- |
| Biodexa Pharmaceuticals PLC | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -48.84% |
| Return on Invested Capital | -89.94% |
| Gross Profit Margin (Quarterly) | 80.63% |
| Operating Margin (Quarterly) | -167.3% |
| Return on Net Operating Assets | -96.45% |